Literature DB >> 21731164

Use of complementary and alternative medicine by cancer patients at Zhejiang University Teaching Hospital Zhuji Hospital, China.

Lisong Teng1, Ketao Jin, Kuifeng He, Chunge Bian, Weili Chen, Kaiyan Fu, Tieming Zhu, Zhigang Jin.   

Abstract

Complementary and alternative medicine (CAM) is garnering increasing interest and acceptance among the general population throughout the world. The use of CAM by cancer patients is very common in China. The referenced English literature has no rural community-based study from China on this subject. This study was conducted to define the prevalence, pattern of use, and reasons for using CAM by cancer patients at Zhejiang University Teaching Hospital Zhuji Hospital (ZUTH-ZJH), China. Face-to-face interviews using a structured questionnaire were used to determine the use of CAM by cancer patients. All consenting cancer patients were interviewed as they presented at the Department of Surgical Oncology of ZUTH-ZJH, from September 2009 to February 2010. One hundred and twenty one patients were interviewed; 64 (52.9%) were males and 57 (47.1%) were females. One hundred and thirteen patients (93.4%) have used CAM at some time during their current cancer illness, fifty two (46.0%) are female and sixty one (54.0%) are male patients; 8 (6.6%) patients have not used any form of CAM. Chinese medicine (73.5.0%) was the most commonly reported CAM modality. Over 71.7% of those who used CAM were satisfied, only 28.3% were disappointed. Twenty eight users (24.8%) did not see any benefit from the CAM, but eighty one patients (71.7%) could describe some specific benefits. Only one patient will use orthodox medicine instead of CAM in the future, almost all patients will continue to use CAM in the future. CAM use is very common among cancer patients in local area of China. Most users obtain the expected benefits, and adverse events are uncommon. It is imperative that oncologists should explore the use of CAM with their cancer patients and work towards an integrated model of health-care provision. This knowledge will enable oncologists to better counsel the patients.

Entities:  

Keywords:  China; cancer; complementary and alternative medicine

Mesh:

Year:  2010        PMID: 21731164      PMCID: PMC3005395          DOI: 10.4314/ajtcam.v7i4.56699

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  18 in total

1.  Use of complementary medicine by adult patients participating in cancer clinical trials.

Authors:  A Sparber; L Bauer; G Curt; D Eisenberg; T Levin; S Parks; S M Steinberg; J Wootton
Journal:  Oncol Nurs Forum       Date:  2000-05       Impact factor: 2.172

Review 2.  Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies.

Authors:  A Sparber; J C Wootton
Journal:  J Altern Complement Med       Date:  2001-06       Impact factor: 2.579

3.  Quality of life and patterns of nontraditional therapy use by patients with cancer.

Authors:  M L Jordan; L R Delunas
Journal:  Oncol Nurs Forum       Date:  2001-08       Impact factor: 2.172

4.  Use of complementary and alternative medicine among women with gynecologic cancers.

Authors:  Elizabeth M Swisher; David E Cohn; Barbara A Goff; Judy Parham; Thomas J Herzog; Janet S Rader; David G Mutch
Journal:  Gynecol Oncol       Date:  2002-03       Impact factor: 5.482

5.  Prevalence of complementary and alternative medicine use in cancer patients.

Authors:  B J Bernstein; T Grasso
Journal:  Oncology (Williston Park)       Date:  2001-10       Impact factor: 2.990

6.  Use of unconventional therapies by children with cancer at an urban medical center.

Authors:  K M Kelly; J S Jacobson; D D Kennedy; S M Braudt; M Mallick; M A Weiner
Journal:  J Pediatr Hematol Oncol       Date:  2000 Sep-Oct       Impact factor: 1.289

7.  Alternative medicine use worldwide: the International Union Against Cancer survey.

Authors:  B R Cassileth; S Schraub; E Robinson; A Vickers
Journal:  Cancer       Date:  2001-04-01       Impact factor: 6.860

8.  Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs.

Authors:  Ruth E Patterson; Marian L Neuhouser; Monique M Hedderson; Stephen M Schwartz; Leanna J Standish; Deborah J Bowen; Lynn M Marshall
Journal:  J Altern Complement Med       Date:  2002-08       Impact factor: 2.579

9.  'Thinking outside the box': complementary and alternative therapies use in paediatric oncology patients.

Authors:  Alexander Molassiotis; Denise Cubbin
Journal:  Eur J Oncol Nurs       Date:  2004-03       Impact factor: 2.398

10.  Complementary medicine in the primary care setting: Results of a survey of gender and cultural patterns in Israel.

Authors:  Eran Ben-Arye; Sonia Karkabi; Chen Shapira; Elad Schiff; Ofer Lavie; Yael Keshet
Journal:  Gend Med       Date:  2009-07
View more
  11 in total

1.  Use of Chinese herbal medicine therapies in comprehensive hospitals in central China: A parallel survey in cancer patients and clinicians.

Authors:  Gang Chen; Ting-Ting Qiao; Hao Ding; Chen-Xi Li; Hui-Ling Zheng; Xiao-Ling Chen; Shao-Ming Hu; Shi-Ying Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

2.  Complementary and alternative medicine (CAM) information and support needs of Chinese-speaking cancer patients.

Authors:  Lynda G Balneaves; M E Wong; A J Porcino; T L O Truant; S E Thorne; S T Wong
Journal:  Support Care Cancer       Date:  2018-06-03       Impact factor: 3.603

Review 3.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

4.  Use of chinese herb medicine in cancer patients: a survey in southwestern china.

Authors:  Tai-Guo Liu; Shao-Quan Xiong; Yan Yan; Hong Zhu; Cheng Yi
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-11       Impact factor: 2.629

5.  A survey of complementary and alternative medicine use in cancer patients treated with radiotherapy in Thailand.

Authors:  Putipun Puataweepong; Nongnuj Sutheechet; Panjachat Ratanamongkol
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-23       Impact factor: 2.629

6.  Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.

Authors:  Xiao-Bing Yang; Wan-Yin Wu; Shun-Qin Long; Hong Deng; Zong-Qi Pan; Wen-Feng He; Yu-Shu Zhou; Gui-Ya Liao; Qiu-Ping Li; Shu-Jing Xiao; Jiao-Zhi Cai
Journal:  Trials       Date:  2015-04-10       Impact factor: 2.279

Review 7.  Pharmacogenomics and herb-drug interactions: merge of future and tradition.

Authors:  Mou-Ze Liu; Yue-Li Zhang; Mei-Zi Zeng; Fa-Zhong He; Zhi-Ying Luo; Jian-Quan Luo; Jia-Gen Wen; Xiao-Ping Chen; Hong-Hao Zhou; Wei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

8.  Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.

Authors:  Jin-Mu Yi; Young Ah Kim; You Jin Lee; Ok-Sun Bang; No Soo Kim
Journal:  BMC Complement Altern Med       Date:  2015-12-18       Impact factor: 3.659

Review 9.  Spiritual Therapy in Coping with Cancer as a Complementary Medical Preventive Practice.

Authors:  Abolfazl Movafagh; Mohammad Hassan Heidari; Morteza Abdoljabbari; Neda Mansouri; Afsoon Taghavi; Aliasghar Karamatinia; Narjes Mehrvar; Mehrdad Hashemi; Mona Ghazi
Journal:  J Cancer Prev       Date:  2017-06-30

10.  HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.

Authors:  Sema Koçaşlı; Zehra Demircan
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.